Trial Profile
A Phase II Study of Sequential Capecitabine Plus Oxaliplatin (XELOX) Followed by Docetaxel Plus Capecitabine (TX) in Patients With Unresectable Gastric
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel; Oxaliplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 12 Apr 2011 New trial record